229 related articles for article (PubMed ID: 1424169)
1. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide.
De Rosa G; Testa A; Liberale I; Pirronti T; Granone P; Picciocchi A
Exp Clin Endocrinol; 1993; 101(5):319-25. PubMed ID: 8299710
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6.
Jansson JO; Svensson J; Bengtsson BA; Frohman LA; Ahlman H; Wängberg B; Nilsson O; Nilsson M
Clin Endocrinol (Oxf); 1998 Feb; 48(2):243-50. PubMed ID: 9579239
[TBL] [Abstract][Full Text] [Related]
4. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin).
Hearn PR; Reynolds CL; Johansen K; Woodhouse NJ
Clin Endocrinol (Oxf); 1988 Feb; 28(2):181-5. PubMed ID: 2844445
[TBL] [Abstract][Full Text] [Related]
5. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
7. [Successful conservative treatment of bronchial carcinoid with Cushing's syndrome due to ectopic ACTH production].
Herrlinger JD; Euler HH; Kleine L; Kirmse L; Müller-Hermelink HK; Löffler H
Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1200-4. PubMed ID: 6872874
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.
Iwayama H; Hirase S; Nomura Y; Ito T; Morita H; Otake K; Okumura A; Takagi J
BMC Endocr Disord; 2018 Mar; 18(1):19. PubMed ID: 29587720
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid-associated ectopic ACTH syndrome with variable response to octreotide.
Gill GV; Yong A; Power E; Ramage J
Postgrad Med J; 1999 Feb; 75(880):98-100. PubMed ID: 10448471
[TBL] [Abstract][Full Text] [Related]
10. Failure of somatostatin analogue SMS 201-995 to control Cushing's syndrome due to ectopic release of ACTH from a bronchial carcinoid.
Burrell L; Gray CE; Thomson JA
Scott Med J; 1989 Oct; 34(5):533-4. PubMed ID: 2555918
[TBL] [Abstract][Full Text] [Related]
11. Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide.
Van den Bruel A; Bex M; Van Dorpe J; Heyns W; Bouillon R
Clin Endocrinol (Oxf); 1998 Oct; 49(4):541-6. PubMed ID: 9876354
[TBL] [Abstract][Full Text] [Related]
12. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
13. Ectopic Cushing's syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide.
Rodrigues P; Castedo JL; Damasceno M; Carvalho D
Arq Bras Endocrinol Metabol; 2012 Oct; 56(7):461-4. PubMed ID: 23108752
[TBL] [Abstract][Full Text] [Related]
14. Cyclical Cushing's syndrome due to an atypical thymic carcinoid.
Meinardi JR; van den Berg G; Wolffenbuttel BH; Kema IP; Dullaart RP
Neth J Med; 2006 Jan; 64(1):23-7. PubMed ID: 16421439
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).
Invitti C; de Martin M; Brunani A; Piolini M; Cavagnini F
Clin Endocrinol (Oxf); 1990 Mar; 32(3):275-81. PubMed ID: 2160871
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
17. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome.
Woodhouse NJ; Dagogo-Jack S; Ahmed M; Judzewitsch R
Am J Med; 1993 Sep; 95(3):305-8. PubMed ID: 8396322
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
19. Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling.
Burman P; Lethagen A; Ivancev K; Johansson L; Sundin A
Eur J Endocrinol; 2008 Oct; 159(4):483-8. PubMed ID: 18625689
[TBL] [Abstract][Full Text] [Related]
20. Ectopic Cushing's syndrome in a young female with atypical [corrected] bronchial carcinoid tumour.
Loh KC; Yap WM; Chia FK
Singapore Med J; 1997 Jan; 38(1):29-31. PubMed ID: 9269352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
